Faheem Hasnain is a businessperson who founded Gossamer Bio, Inc. and who has been the head of 11 different companies. Mr. Hasnain holds the position of Chairman of Mirati Therapeutics, Inc., Chairman of SENTÉ, Inc. (California), Chairman, President & Chief Executive Officer for Gossamer Bio, Inc. and Chairman at Aspen Neuroscience, Inc. Mr. Hasnain is also on the board of Kura Oncology, Inc. and Member-Overseers Board at The Scripps Research Institute. In the past Faheem Hasnain held the position of President, Chief Executive Officer & Director at PDL BioPharma, Inc., President-Oncology Therapeutics Network at Bristol Myers Squibb Co. and President, Chief Executive Officer & Director at Receptos LLC (a subsidiary of Bristol Myers Squibb Co.), Executive Vice President at Biogen, Inc. and EVP-Oncology & Rheumatology Strategic Business at Biogen Idec, Inc. (North Carolina) (a subsidiary of Biogen, Inc.), Vice President-Global eBusiness at GlaxoSmithKline Plc, Chairman for Ambit Biosciences Corp., Chairman at Tocagen, Inc., Chairman at Vital Therapies, Inc., President, Chief Executive Officer & Director at Abbott Biotherapeutics Corp. and President for Oncology Therapeutics Network Corp. Mr. Hasnain received an undergraduate degree from the University of Windsor.